105th Congress / Bills / S 830
Title
A bill to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products, and for other purposes.
Read more information on this bill at the Library of Congress.
Categories (What are categories?)
Administrative fees | Administrative procedure -- Department of Health and Human Services | Administrative remedies | Advertising | Agriculture | Allergies | Animals | Antibiotics | Artificial implants | Authorization | Beef | Bibliography | Biomedical engineering | Blood | Budgets | Business | Business records | Cadmium | Cancer | Ceramics | Chemotherapy | Child health | Children | Citizen participation | Civil liberties | Clinical trials | Communication in medicine | Communication in science | Communications | Computer software | Computers and government | Conferences | Conflict of interests | Congress | Congressional investigations | Congressional oversight | Congressional reporting requirements | Consumer education | Consumers | Cosmetics | Criminal justice | Data banks | Deceptive advertising | Defective products | Delegation of powers | Diabetes | Dietary supplements | Donation of organs, tissues, etc. | Drug abuse | Drug addiction | Drug adulteration | Drug approvals | Drug industry | Drug therapy | Drug utilization | Drugs | Economic impact statements | Economic policy | Education | Emergency management | Emergency medicine | Employee training | Environmental assessment | Environmental protection | Epidemiology | Executive departments | Export controls | Exports | Federal advisory bodies | Federal aid to medical education | Federal aid to medical research | Federal aid to research | Federal employees | Federal preemption | Federal-state relations | Finance | Food | Food additives | Food adulteration and inspection | Food industry | Food irradiation | Food labeling | Food safety | Foreign policy | Freedom of information | Glass and glass industry | Government and business | Government employees | Government ethics | Government information | Government paperwork | Government publications | Government publicity | Government regulation | Government service contracts | Government statistics | Governmental investigations | Grants-in-aid | Hazardous substances | Health insurance | Health insurance industry | Health maintenance organizations | Health policy | Health warnings | Higher education | Hospitals | Human experimentation in medicine | Imaging systems in medicine | Import restrictions | Imports | Information storage and retrieval systems | Insulin | Intellectual property | International affairs | International cooperation | International cooperation in science | Interstate commerce | Job training | Judicial review of administrative acts | Labeling | Law | Lead | Licenses | Local laws | Managed care | Management audit | Management information systems | Manufacturing industries | Margarine | Meat | Medical associations | Medical care | Medical economics | Medical education | Medical instruments and apparatus | Medical instruments and apparatus -- Standards | Medical laboratories | Medical records | Medical research | Medical tests | Medicated feeds | Medication abuse | Medicine | Mercury | Mercury poisoning | Minorities | Minority health | New products | Nonprescription drugs | Nuclear medicine | Nursing homes | Nutrition | Orphan drugs | Packaging | Paints and varnishes | Patents | Patients' rights | Pediatrics | Periodicals | Pharmaceutical research | Pharmacists | Physicians | Planning-programming-budgeting | Politics and government | Preventive medicine | Product development | Product safety -- Standards | Public contracts | Quality of care | Radiation safety | Radioisotopes in medicine | Radiotherapy | Recombinant DNA | Religion | Religious liberty | Research and development contracts | Research centers | Research ethics | Research grants | Right of privacy | Scholarships | Science and ethics | Science policy | Scientists | Searches and seizures | Skin cancer | Skin diseases | Small business | State and local government | State laws | Sun | Technological innovations | Technology | Telephone | Test facilities | Textbooks | Tissue banks | Tobacco | Tobacco industry | Trade | Trade agreements | Trade secrets | Transportation | Vaccines | Veterinary medicine | Virus research | Wholesale trade | Women | Women's health
Votes on this bill
| Date | Chamber | Result | Vote |
|---|---|---|---|
| Senate | Session 1, roll call 256: On Passage of the Bill s.830 as amended; Food and Drug Administration Modernization Act of 1997 |
||
| Senate | Session 1, roll call 255: On the Amendment modified committee substitute no. 1130 as modified; To provide a complete substitute. |
||
| Senate | Session 1, roll call 254: On the Motion to Table motion to table reed (ri) amdt no. 1177; To ensure that determinations of the Secretary with respect to the intended uses of a device are based on the proposed labeling only if such labeling is not false or misleading. |
||
| Senate | Session 1, roll call 253: On the Amendment durbin amendment no. 1139; To eliminate provisions relating to the discretion of the Secretary of Health and Human Services to track devices or to conduct postmarket surveillance of devices. |
||
| Senate | Session 1, roll call 252: On the Amendment durbin amendment no. 1140; To require that entities and individuals accredited to conduct reviews of device notifications be subject to the conflict of interest standards that apply to employees of the Food and Drug Administration. |
